From: The financial impact of increasing home-based high dose haemodialysis and peritoneal dialysis
 | PD | Conventional ICHD | High dose ICHD | Conventional home HD | High dose HD at home | PbR tariff |
---|---|---|---|---|---|---|
Prevalent patients (%) | ||||||
Reference scenario | 14.1 | 82.0 | 0.0 | 3.9 | 0.0 | Current |
Scenario 1 | 14.1 | 72.0 | 0.0 | 3.9 | 10.0 | Current |
Scenario 2 | 14.1 | 72.0 | 0.0 | 3.9 | 10.0 | High dose HD at home: increased to £575. |
 | All other modalities: current | |||||
Scenario 3 | 20.0 | 66.1 | 0.0 | 3.9 | 10.0 | High dose HD at home: increased to £575. |
 | All other modalities: current | |||||
Scenario 4 | 25.0 | 61.1 | 0.0 | 3.9 | 10.0 | High dose HD at home: increased to £575. |
 | All other modalities: current | |||||
Scenario 5 | 0.0 | 100.0 | 0.0 | 0.0 | 0.0 | Current |
Incident patients (%) | ||||||
Reference scenario | 22.9 | 77.1 | 0.0 | 0.0 | 0.0 | Current |
Scenario 1 | 22.9 | 77.1 | 0.0 | 0.0 | 0.0 | Current |
Scenario 2 | 22.9 | 77.1 | 0.0 | 0.0 | 0.0 | Current |
Scenario 3 | 31.0 | 69.0 | 0.0 | 0.0 | 0.0 | Current |
Scenario 4 | 39.0 | 61.0 | 0.0 | 0.0 | 0.0 | Current |
Scenario 5 | 0.0 | 100.0 | 0.0 | 0.0 | 0.0 | Current |